| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000025463 |
| Receipt No. | R000029295 |
| Scientific Title | Safety and efficacy of preoperative biliary drainage using plastic stent above the sphincter of Oddi (Inside-stent) in patients with malignant hilar biliary obstruction: A prospective study |
| Date of disclosure of the study information | 2017/01/30 |
| Last modified on | 2021/01/04 (Ver. 3) |
| Basic information | ||
| Public title | Safety and efficacy of preoperative biliary drainage using plastic stent above the sphincter of Oddi (Inside-stent) in patients with malignant hilar biliary obstruction: A prospective study
|
|
| Acronym | Safety and efficacy of preoperative biliary drainage using plastic stent above the sphincter of Oddi (Inside-stent) in patients with malignant hilar biliary obstruction: A prospective study | |
| Scientific Title | Safety and efficacy of preoperative biliary drainage using plastic stent above the sphincter of Oddi (Inside-stent) in patients with malignant hilar biliary obstruction: A prospective study
|
|
| Scientific Title:Acronym | Safety and efficacy of preoperative biliary drainage using plastic stent above the sphincter of Oddi (Inside-stent) in patients with malignant hilar biliary obstruction: A prospective study | |
| Region |
|
|
| Condition | |||
| Condition | Resectable malignant hilar biliary obstruction | ||
| Classification by specialty |
|
||
| Classification by malignancy | Malignancy | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | To evaluate the efficancy and safety of plastic stent placement above the sphincter of Oddi for patients of resectable malignant hilar biliary obstruction. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Exploratory |
| Trial characteristics_2 | Pragmatic |
| Developmental phase | Phase II |
| Assessment | |
| Primary outcomes | Time to recurrent biliary obstruction of inside-sten |
| Key secondary outcomes | 1. Overall number of re-intervention after initial biliary drainage
2. Success rate and complication rate of inside-stent placement 3. Recurrent biliary obstruction rate of inside-stent 4. Overall morbidity and infectious complication rate after surgery |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Uncontrolled |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | In undrainage patients, the site of biliary structure was confirmed endoscopically and naso-biliary drainage (ENBD) was performed firstly. After relieve of jaundice, ENBD was exchanged for inside-stent. In patients who had undergone endoscopic biliary drainage in previous hospital, endoscopic examination is performed and the existing stent was exchanged for inside-stent. | |
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1. Resectable biliary tract cancer (intrahepatic, perihilar, or distal cholangiocarcinoma, gallbladder carcinoma) with obstructive jaundice
2. Life expectancy > 3 months 3. Endoscopic preoperative biliary drainage or radical surgery can be performed safely. 4. Endoscopic cholangiography shows the distance from the stricture to the sphincter of Oddi is at least 3cm. 5. Patients of age >= 20 years 6. ECOG performance status of 0-2 7. ASA calassification of 0-2 8. Adequate organ function 9. Written informed consent is required from all patients. |
|||
| Key exclusion criteria | 1. History of radiotherapy, chemotherapy or immunotherapy for malignant disease before starting the study treatment
2. Preoperative biliary drainage is not needed. 3. PTBD has been performed at previous hospital. 4. Severe complications such as intestinal pneumonia, pulmonary fibrosis, and heart failure 5. Psychosis or severe mental disorder 6. Pregnant or lactating female and patients who is considering pregnancy 7. Inappropriate patients for entry on this study in the judgement of the investigator |
|||
| Target sample size | 30 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Japanese foundation for cancer research, Cancer institute hospital | ||||||
| Division name | Department of Gastroenterological Surgery | ||||||
| Zip code | |||||||
| Address | 3-8-31 Ariake, Koto-ku, Tokyo, Japan | ||||||
| TEL | +81-3-3520-0111 | ||||||
| akio.saiura@jfcr.or.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Japanese foundation for cancer research, Cancer institute hospital | ||||||
| Division name | Department of Gastroenterological Surgery | ||||||
| Zip code | |||||||
| Address | 3-8-31 Ariake, Koto-ku, Tokyo, Japan | ||||||
| TEL | +81-3-3520-0111 | ||||||
| Homepage URL | |||||||
| yu.takahashi@jfcr.or.jp | |||||||
| Sponsor | |
| Institute | Japanese foundation for cancer research, Cancer institute hospital |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Japanese foundation for cancer research, Cancer institute hospital |
| Organization | |
| Division | |
| Category of Funding Organization | Non profit foundation |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | |
| Address | |
| Tel | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000029295 |